driving the future with Biokansas

Biologics and small molecules: Access to research and infrastructure in the heartland

About

The Event

November 8, 2021  |  7:30 am – 5 pm (central time)

Chemically synthesized drugs, as well as those isolated from a variety of natural sources, continue to be essential for one health worldwide. In addition to the research expertise and infrastructure required for continued conventional drug development, there is also a need for gene-based therapy, stem-cell therapy, and precision therapy research capabilities. As scientists continue to research lifesaving remedies, access to contract nonclinical/clinical research and manufacturing support is vital to the success of the bioscience industry. 

This event will explore the intricate needs of the bioscience industry and brings together a range of diverse company’s developing small molecule and biologic therapies for dedicated panel discussions. 

Attendees will also have the opportunity to visit contract research laboratories in Kansas City.

Join the symposium to:

  • Ask direct questions of and connect with industry leaders
  • Learn of the intricate needs of the industry
  • Understand how contract research and contract manufacturing companies are vital to the success of the industry.

Agenda

November 7, 2021

4:00 – 8:00 PM

Sporting KC vs Real Salt Lake (Special event for speakers and sponsors)

November 8, 2021

7:30 AM

Registration

8:00 AM

Bus Tour

12:00 PM

Lunch and Invited Presentations

1:00 PM

Panel Discussion: Small Molecule and Biologics Research in the Nonclinical Environment

2:00 PM

Panel Discussion: Vaccines, Medical Devices, Biologics, and Small Molecules in the Clinical Research Environment

3:00 PM

Panel Discussion: Biologics and Small Molecule Contract Development and Manufacturing

4:00 PM

State of the CRO Industry

5:00 PM

Closing Remarks

Meet the Speakers

Jeff Folks

Director, Business Development - Adare Pharma Solutions

Tim LaBranche, DVM, PhD

Vice President, Preclinical Safety & Comparative Medicine - Blueprint Medicines

Stephanie Pasas-Farmer, PhD

President and Founder - Ariadne Software Principle Scientist and Founder - BioData Solutions

Andrew Fowlie, PhD

Chief Operating Officer - Seeing Medicines, Inc.

Jiewu Liu, PhD

Director, Bioanalytical Sciences - Kriya Therapeutics

Darrel J. Rezac, PhD

Senior Consultant - Latham Biopharm Group

Jack Treml, PhD

Assistant Program Director, Biotechnology and Professor of Practice - University of Kansas

Janet DeLeon

CEO - DeLeon Pharmaceutical Consulting, LLC

Randall Logan, PhD

Program Director, Biotechnology and Professor of Practice - University of Kansas

Stephen Snyder

President - Outsourcing Support Services, Inc.

Event Moderators

John Bucksath

Chief Executive Officer KCAS Bioanalytical and Biomarker Services

Alfred Botchway, PhD

Chief Executive Officer Attentive Science

Event Sponsors

Vendors

Listen, Share, & Advance Kansas